TMEM25 and nonpapillary renal cell carcinoma: Several studies have shown that TMEM25 is involved in the regulation of tumourigenesis and progression, and in the present study, we found that TMEM25 may be acting as an oncogene in ccRCC, which is a new biomarker with great potential in the diagnosis and prognosis of ccRCC.